(PharmaNewsWire.Com, December 23, 2019 ) Market Overview The global medical simulation market is forecasted to grow at a CAGR of 13.2% during the forecast period (2019-2026).
Medical Simulation is the modern-day methodology for training healthcare professionals through the use of advanced educational technology. Medical simulation is the experiential learning every healthcare professional will need but cannot always engage in during real-life patient care.
During fully immersive medical simulation learners enter into a realistic healthcare setting where a high-fidelity patient manikin is being wirelessly operated by both educational and simulation technical staff. Medical Simulation has been proven to reduce medical errors and the associated costs all while improving outcomes in patient care
Market Dynamics Technological advancements are primarily driving the global medical simulation market in recent years and expected to remain the same over the forecast period. Technological advancements are creating realistic learning environments and increasing patient safety. For instance, in 2018, Laerdal Medical announced the launch of their new simulation training technology, SimMan Vascular. The new technology will support the multidisciplinary team training and provides immersive training to all members of the acute care team, including endovascular specialists, interventional radiologists, resuscitation teams, and pre-hospital care providers.
Increasing focus on patient safety is boosting the global simulation market. Simulation in health care creates a safe learning environment that allows researchers and practitioners to test new clinical processes and enhance individual and team skills before encountering patients. Simulation has the potential to improve the safety of health care by allowing health care practitioners to acquire valuable experience, in a variety of clinical settings, without putting patients at risk. The Agency for Healthcare Research and Quality (AHRQ) supports simulation research through its patient safety program and in 2011, AHRQ funded 11 multi-year demonstration grants to evaluate the use and effectiveness of various simulation approaches and the role they can play in improving the safety and quality of health care delivery.
Limited access to live patients and the medical technology revolution are further surging global medical simulation market over the forecast period.
However, the high cost of installation and budgetary constraints are hampering the medical simulation market.
Market Segmentation Based on type of simulation, global medical simulation market is categorized into manikin-based, standardized patients, computer-assisted instruction, in-situ, human patient simulators, task trainers, medical moulage, multi-disciplinary scenarios, hybrid simulations. Human patient simulators held the highest market share in 2018 and remains to dominate over the forecast period. Human patients stimulators are preferred more as they are integrated with computer software that let them replicate normal and abnormal bodily responses to events and therapeutic interventions. Their heart, blood vessels, lungs and gastrointestinal tract can be made to respond to any number of human interventions. For instance, Samuel Merritt University developed Simbaby human simulator that responds physiologically, via computer, to the care being given. SimBaby® has an IV arm and IV/IO legs, for practising peripheral intravenous and intraosseus therapy.
Based on end-user global medical simulation market is classified into hospitals, academic institutions and research organizations. Academic institutions accounted for the highest market share and anticipated to remain the same due to the increasing number of medical institutes. For instance, in 2019, in India, The Medical Council of India (MCI) had granted permission for three institutes that covers 350 medical seats.
Research organizations hold the second largest market share due to the increasing number of clinical researches.
Geographical Analysis The global medical simulation market is segmented into North America, Europe, Asia Pacific, South America and the Middle East and Africa.
North America dominates the global medical simulation due to technological advancements, government initiatives and an increasing number of medical institutes. According to the Association of American Medical Colleges, in the United States, there are 179 medical schools and anticipated to increase further.
Europe holds the second largest market share as the number of medical institutes and clinical researches are increasing in recent years. According to NHS in 2018, in the UK, there are 33 medical colleges that are recognized by the General Medical Council.
Asia Pacific is registering the fastest CAGR due to the increasing number of manufacturers and technological advancements in countries such as India, China and Japan.
Competitive Analysis Companies are focusing on key strategies such as collaboration, acquisitions, and product launches which are boosting the growth of the market globally.
The key players in the medical simulation market are CAE, Laerdal Medical, Limbs & Things, Kyoto Kagaku, Mentice, Medaphor, Gaumard Scientific Company, 3D Systems, Simulab Corporation and Simulaids.
On January 25, 2019, EMS launched a telemedicine simulation platform for virtual, online, live, and mobile medical training.
On January 13, 2018, Laerdal Medical launched two new infant simulators, SimNewB® and SimBaby™ at the International Meeting on Simulation in Healthcare (IMSH) conference in Los Angeles, California.
On September 20, 2017, Laerdal Medical introduced its new Nursing Anne Simulator during the National League for Nursing (NLN) Summit to support the training and core nursing competencies.
About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
